Edition:
United States

Probi AB (PROB.ST)

PROB.ST on Stockholm Stock Exchange

542.00SEK
23 May 2017
Change (% chg)

-- (--)
Prev Close
542.00kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,866
52-wk High
574.00kr
52-wk Low
156.15kr

Latest Key Developments (Source: Significant Developments)

Probi Q1 operating profit rises to SEK 56.0 million
Thursday, 4 May 2017 02:00am EDT 

May 4 (Reuters) - PROBI AB :Q1 NET SALES SEK 187.4 MILLION VERSUS SEK 87.0 MILLION YEAR AGO.Q1 OPERATING PROFIT SEK 56.0 MILLION VERSUS SEK 35.3 MILLION YEAR AGO.  Full Article

Probi appoints Jörn Andreas new CFO
Tuesday, 14 Feb 2017 02:00am EST 

Probi AB : Probi appoints Jörn Andreas new CFO .Jörn Andreas will replace Niklas Brandt who will remain in probis leadership team as CIO.  Full Article

Probi Q4 operating profit up at SEK 43.6 million
Tuesday, 24 Jan 2017 02:00am EST 

Probi AB : Q4 net sales 194.0 million Swedish crowns ($21.94 million) versus 35.9 million crowns year ago . Q4 operating profit 43.6 million crowns versus 3.7 million crowns year ago .Proposes dividend for 2016 totaling 11.6 million crowns corresponding to 1.00 crown per share.  Full Article

Probi Q4 preliminary net sales up by SEK 158 million
Tuesday, 10 Jan 2017 02:00am EST 

Probi AB : Q4 net sales up by 158 million Swedish crowns ($17.5 million) at 194 million crowns .FY operating profit 130 million crowns versus 63 million crowns year ago.  Full Article

Probi decides on rights issue and announces terms
Thursday, 29 Sep 2016 01:00am EDT 

Probi AB : Decides on rights issue and announces terms . Rights issue comprises no more than 2,278,825 shares . Total issue proceeds of about 602 million Swedish crowns ($70.30 million) before issue costs, assuming that rights issue is fully subscribed .Subscription price has been set to 264 crowns per new share.  Full Article

Probi Q2 operating profit up at SEK 20.7 million
Friday, 15 Jul 2016 02:45am EDT 

Probi AB : Q2 net sales 73.3 million Swedish crowns ($8.6 million) versus 59.0 million crowns year ago .Q2 operating profit 20.7 million crowns versus 15.7 million crowns year ago.  Full Article

Probi to buy Nutraceutix and expand into North American market
Tuesday, 7 Jun 2016 03:20am EDT 

Probi AB : Probi to acquire Nutraceutix, expanding its North American presence and capabilities . Announces rights issue of about 600 million Swedish crowns ($74 million) . To acquire Nutraceutix for a preliminary cash purchase price of $105 million (873 million Swedish crowns) on a cash and debt free basis . Will increase its market share in North America more than three-fold . Cash purchase price will be financed through available cash reserves, a credit facility of about $35 million and a bridge facility of about $63 million . Handelsbanken has committed to provide the credit facility and the bridge facility .Bridge facility will be repaid by proceeds from the rights issue of about 600 million crowns.  Full Article

Probi to buy Nutraceutix and expand into North American market
Monday, 6 Jun 2016 03:00pm EDT 

Probi AB : Probi to acquire Nutraceutix, expanding its North American presence and capabilities . Announces rights issue of about 600 million Swedish crowns ($74 million) . To acquire Nutraceutix for a preliminary cash purchase price of $105 million (873 million Swedish crowns) on a cash and debt free basis . Will increase its market share in North America more than three-fold . Cash purchase price will be financed through available cash reserves, a credit facility of about $35 million and a bridge facility of about $63 million . Handelsbanken has committed to provide the credit facility and the bridge facility .Bridge facility will be repaid by proceeds from the rights issue of about 600 million crowns.  Full Article

Probi signs new agreements in Functional Food and Consumer Healthcare
Tuesday, 31 May 2016 05:45am EDT 

Probi AB : Signs new agreements in Functional Food and Consumer Healthcare . Has signed agreements with three different partners in Sweden, Iceland and Austria .European launch is planned for second half of 2016.  Full Article

Probi AB signs primary care distribution agreement with Ipsen
Tuesday, 26 Apr 2016 02:45am EDT 

Probi AB:Probi and Ipsen sign primary care distribution agreement for probiotic LP299V, Lactobacillus plantarum 299v.Agreement covers 18 countries, primarily within EU and emerging markets.Probi will supply bulk LP299V capsules and Ipsen will be responsible for packaging, marketing and selling product.Product is expected to be launched in H1 2017 as a food supplement in European markets.Product is expected to be launched in other key markets such as Russia and China, depending on regulatory approval.  Full Article

More From Around the Web

BRIEF-Probi Q1 operating profit rises to SEK 56.0 million

* Q1 NET SALES SEK 187.4 MILLION VERSUS SEK 87.0 MILLION YEAR AGO